Home › Funds › SCHRODER INVESTMENT MANAGEMENT GROUP › BMY

SCHRODER INVESTMENT MANAGEMENT GROUP position in BMY

BRISTOL-MYERS SQUIBB CO · Health Care

SCHRODER INVESTMENT MANAGEMENT GROUP reported holding 12,095,818 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q3 2026 13F filing — a position valued at US$760.3M, representing 0.53% of its reported portfolio and ranking #32 among its reported holdings. SCHRODER INVESTMENT MANAGEMENT GROUP has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)12.10M sh
Reported value held$760.34M
Portfolio Weight0.53%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How SCHRODER INVESTMENT MANAGEMENT GROUP's BMY position evolved

SCHRODER INVESTMENT MANAGEMENT GROUP first disclosed a stake in BMY in Q3 2023 at 2,768,528 shares (US$160.7M). The position peaked in Q3 2026 at 12,095,818 shares, worth US$760.3M. Across 13 filings, SCHRODER INVESTMENT MANAGEMENT GROUP increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 12,095,818 shares valued at US$760.3M — a reduction of -131,136 shares quarter over quarter.. Notable position changes include a 46% increase in Q2 2024 (shares rose 26% over the following quarter), a 50% increase in Q4 2024 (shares rose 9% over the following quarter), a 35% increase in Q2 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.77M $160.69M New
Q4 2023 3.47M $177.84M Add
Q1 2024 4.57M $247.96M Add
Q2 2024 6.67M $277.15M Add
Q3 2024 7.63M $394.59M Add
Q4 2024 11.41M $639.84M Add
Q1 2025 10.11M $616.62M Reduce
Q2 2025 13.69M $633.90M Add
Q3 2025 12.17M $548.82M Reduce
Q4 2025 12.55M $680.57M Add
Q1 2026 12.24M $742.08M Reduce
Q2 2026 12.23M $716.01M Hold
Q3 2026 12.10M $760.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMY and 13F data

BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 25 other funds we track also report a position in BMY — the largest reported positions include CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$4.52B), Charles Schwab Investment Management (US$3.89B), AQR Capital Management (US$1.58B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMY

All BMY fund holders →

FAQ

How long has SCHRODER INVESTMENT MANAGEMENT GROUP held BMY?

SCHRODER INVESTMENT MANAGEMENT GROUP has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SCHRODER INVESTMENT MANAGEMENT GROUP's current position in BMY?

As of Q3 2026, SCHRODER INVESTMENT MANAGEMENT GROUP holds 12.10M shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $760.34M, representing 0.53% of its reported portfolio and ranking #32.

Has SCHRODER INVESTMENT MANAGEMENT GROUP been buying or selling BMY?

In the latest 13F filing (Q3 2026), SCHRODER INVESTMENT MANAGEMENT GROUP reduced its position in BMY. The position peaked in Q3 2026 at 12.10M shares.

Which other funds hold BMY?

Other major institutional holders of BMY include CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, AQR Capital Management, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.